The complex IGF-II and serotonin systems may indeed interrelate, raising the possibility that individuals with BED who are at increased risk of both depression and insulin resistance may display low serotonin levels, which in other systems have been shown to be associated with increased IGF –II expression [14]. The gene discussed is IGF2; the disease is depressive symptom measurement.